Scholarly Index
Karl Tryggvason
Singapore Eye Research Institute; 46,397 total citations; 450 total publications; best world rank #12
Singapore Eye Research Institute
46,397Total citations
450Total publications
114H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Renal Diseases and Glomerulopathies | Lifetime | 12 | SG 1 | 99.79 |
| Cell Adhesion Molecules Research | Lifetime | 30 | SG 1 | 99.82 |
| Protease and Inhibitor Mechanisms | Lifetime | 26 | SG 1 | 99.58 |
| Renal and related cancers | Lifetime | 109 | SG 2 | 99.30 |
| Connective tissue disorders research | Lifetime | 51 | SG 1 | 98.82 |
| Biomedical Research and Pathophysiology | Lifetime | 29 | SG 1 | 98.77 |
| Platelet Disorders and Treatments | Lifetime | 136 | SG 1 | 98.85 |
| Chronic Kidney Disease and Diabetes | Lifetime | 120 | SG 2 | 99.16 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 114 | SG 1 | 98.70 |
| Peptidase Inhibition and Analysis | Lifetime | 534 | SG 4 | 98.14 |
| Proteoglycans and glycosaminoglycans research | Lifetime | 241 | SG 1 | 97.39 |
| Collagen: Extraction and Characterization | Lifetime | 162 | SG 1 | 96.30 |
| TGF-β signaling in diseases | Lifetime | 395 | SG 2 | 94.69 |
| Genetic and Kidney Cyst Diseases | Lifetime | 555 | SG 2 | 93.58 |
| Bone and Dental Protein Studies | Lifetime | 640 | SG 3 | 92.44 |
| Caveolin-1 and cellular processes | Lifetime | 835 | SG 4 | 83.77 |
| Tuberous Sclerosis Complex Research | Lifetime | 873 | SG 5 | 77.29 |